Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study

Kyouhei Yamada, M.D., Morio Sawamura, M.D. Ph.D., Takeshi Shimomura, MD, Makoto Takeuchi, M.D., Shuichi Hanada, Takuya Komeno, MD, PhD, Michihiro Hidaka, MD, PhD, Takahiro Yano, MD, PhD, Kiyoshi Kitano, MD, Isao Yoshida, MD, Nobumasa Inoue, Keizo Horibe, MD, PhD, Watanabe Tomoyuki, Kazutaka Sunami, MD, PhD, Hirokazu Nagai, MD, PhD

Blood (2013) 122 (21): 1797.

https://doi.org/10.1182/blood.V122.21.1797.1797

Published: 2013

Journal Articles

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Yoshihiro Hatta, Shuichi Mizuta, Shigeki Ohtake, MD, PhD, Isamu Sugiura, MD, PhD, Yasunori Ueda, MD, Heiwa Kanamori, Hideki Akiyama, Makoto Takeuchi, Noriko Usui, Toshiaki Yujiri, Atsushi Fujieda, Toru Kiguchi, MD, Itsuro Jinnai, MD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 3090.

https://doi.org/10.1182/blood.V114.22.3090.3090

Published: 2009

Journal Articles

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Shuichi Mizuta, Masamitsu Yanada, Isamu Sugiura, Fumiharu Yagasaki, Toshiaki Yujiri, Makoto Takeuchi, Yoshihiro Hatta, Yukihiko Kimura, Yasunori Ueda, MD, Heiwa Kanamori, Noriko Usui, Hideki Akiyama, Yasushi Miyazaki, MD, PhD, Shigeki Ohtake, Itsuro Jinnai, MD, Keitaro Matsuo, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 462.

https://doi.org/10.1182/blood.V112.11.462.462

Published: 2008

Journal Articles

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Kazuhiro Nishii, MD, Yasunori Ueda, MD, Makoto Takeuchi, MD, Shuichi Miyawaki, MD, Atsuo Maruta, MD, Hiroto Narimatsu, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2007) 110 (11): 2813.

https://doi.org/10.1182/blood.V110.11.2813.2813

Published: 2007

Journal Articles

Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) in Japan: An Analysis from West-Japan Hematology/Oncology Group (West-JHOG) NHL Outcomes Project.

Blood (2006) 108 (11): 4698.

https://doi.org/10.1182/blood.V108.11.4698.4698

Published: 2006

Journal Articles

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL –positive acute lymphoblastic leukemia

Masayuki Towatari, Masamitsu Yanada, Noriko Usui, Jin Takeuchi, Isamu Sugiura, Makoto Takeuchi, Fumiharu Yagasaki, Yasukazu Kawai, Shuichi Miyawaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno, for the Japan Adult Leukemia Study Group

Blood (2004) 104 (12): 3507–3512.

https://doi.org/10.1182/blood-2004-04-1389

Published: 2004

Journal Articles

Combination of Intensive Chemotherapy and Imatinib (IDEAMOP Regimen) for the Treatment of Newly Diagnosed BCR-ABL Positive Acute Lymphoblastic Leukemia; Excellent Efficacy without Increasing Toxicity.

Masamitsu Yanada, MD, Nobuhiko Emi, MD, Noriko Usui, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Makoto Takeuchi, MD, Tohru Kobayashi, MD, Fumiharu Yagasaki, MD, Shigeki Ohtake, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2004) 104 (11): 2736.

https://doi.org/10.1182/blood.V104.11.2736.2736

Published: 2004

Journal Articles

Mosquito allergy and Epstein-Barr virus–associated T/natural killer–cell lymphoproliferative disease

Keisei Kawa, Takayuki Okamura, Keiko Yagi, Makoto Takeuchi, Masahiro Nakayama, Masami Inoue

Blood (2001) 98 (10): 3173–3174.

https://doi.org/10.1182/blood.V98.10.3173

Published: 2001

Journal Articles

Treatment With a New Synthetic Retinoid, Am80, of Acute Promyelocytic Leukemia Relapsed From Complete Remission Induced by All- trans Retinoic Acid

Tadasu Tobita, Akihiro Takeshita, Kunio Kitamura, Kazunori Ohnishi, Mitsuaki Yanagi, Akira Hiraoka, Takahiro Karasuno, Makoto Takeuchi, Shuuichi Miyawaki, Ryuzo Ueda, Tomoki Naoe, Ryuzo Ohno

Blood (1997) 90 (3): 967–973.

https://doi.org/10.1182/blood.V90.3.967

Published: 1997

NARROW

Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) in Japan: An Analysis from West-Japan Hematology/Oncology Group (West-JHOG) NHL Outcomes Project.

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL –positive acute lymphoblastic leukemia

Combination of Intensive Chemotherapy and Imatinib (IDEAMOP Regimen) for the Treatment of Newly Diagnosed BCR-ABL Positive Acute Lymphoblastic Leukemia; Excellent Efficacy without Increasing Toxicity.

Mosquito allergy and Epstein-Barr virus–associated T/natural killer–cell lymphoproliferative disease

Treatment With a New Synthetic Retinoid, Am80, of Acute Promyelocytic Leukemia Relapsed From Complete Remission Induced by All- trans Retinoic Acid

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only